Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy
Abstract Objective Resveratrol is a natural polyphenolic compound that ameliorates postmenopausal osteoporosis by activating the estrogen receptor. Research has shown that resveratrol exhibits some type of estrogen receptor agonist activity, reducing the risk of breast cancer. However, its mechanism...
Main Authors: | Wei Wang, Li-Mei Zhang, Chang Guo, Jian-Feng Han |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Nutrition & Metabolism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12986-020-00449-9 |
Similar Items
-
Resveratrol Ameliorates High Altitude Hypoxia-Induced Osteoporosis by Suppressing the ROS/HIF Signaling Pathway
by: Changqing Yan, et al.
Published: (2022-08-01) -
The Potential of Natural Compounds Regulating Autophagy in the Treatment of Osteoporosis
by: Zhao Y, et al.
Published: (2023-12-01) -
Autophagy in Bone Remodeling: A Regulator of Oxidative Stress
by: Chenyu Zhu, et al.
Published: (2022-06-01) -
Revisiting Resveratrol as an Osteoprotective Agent: Molecular Evidence from In Vivo and In Vitro Studies
by: Haryati Ahmad Hairi, et al.
Published: (2023-05-01) -
POSTMENOPAUSAL OSTEOPOROSIS – AN EXPLORATIVE LITERATURE REVIEW
by: Iulian Ștefan HOLUBIAC, et al.
Published: (2019-12-01)